Artia Global Partners LP Biomarin Pharmaceutical Inc Transaction History

Artia Global Partners LP

  • $367 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$76.22 - $98.51 $3.78 Million - $4.88 Million
-49,580 Reduced 63.19%
28,885 $2.79 Billion
Q2 2023

Aug 14, 2023
SELL
$86.68 - $100.3 $3.47 Million - $4.01 Million
-40,000 Reduced 33.77%
78,465 $6.8 Billion
Q1 2023

May 15, 2023
BUY
$87.74 - $117.27 $7.92 Million - $10.6 Million
90,248 Added 319.84%
118,465 $11.5 Billion
Q4 2022

Feb 14, 2023
BUY
$80.93 - $108.63 $2.28 Million - $3.07 Million
28,217 New
28,217 $2.92 Billion

Others Institutions Holding BMRN

# of Institutions
635
Shares Held
178M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.8B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Artia Global Partners LP Portfolio

Follow Artia Global Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artia Global Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Artia Global Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email